Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma [Phase 1]
Phase 1 clinical trial evaluating irinotecan in combination with cyclosporine and phenobarbital in adults with solid tumors or lymphoma; the…
-
CLINICAL_TRIALS trial_result · 2013-01-30Clinical Trial Update: Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function [Phase 1]
A completed Phase 1 trial assessed temsirolimus in patients with metastatic solid tumors or lymphoma who have varying levels of liver functi…
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: 2-Methoxyestradiol in Treating Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study of 2-methoxyestradiol in patients with refractory or stage III multiple myeloma and other advanced solid tumors has complete…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma [Phase 1]
A completed Phase 1 study evaluating arsenic trioxide with pamidronate in patients with advanced solid tumors or refractory multiple myeloma…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: PDM08 Clinical Trial in Advanced Solid Tumors [Phase 1]
Phase 1 trial PDM08 in advanced malignant solid tumors has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-11-27Clinical Trial Update: LBH589 in Adult Patients With Advanced Solid Tumors or Cutaneous T-cell Lymphoma [Phase 1]
A Phase 1 trial of LBH589 (panobinostat) in adults with advanced solid tumors or cutaneous T-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-31Clinical Trial Update: Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors [Phase 1]
The Phase 1 dose-finding study of CP-870,893 in combination with paclitaxel and carboplatin for patients with metastatic solid tumors has co…
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Valproic Acid-Based 2-Agent Oral Regimens for Patients With Advanced Solid Tumor [Phase 1]
Phase 1 trial evaluating valproic acid-based two-agent oral regimens in patients with advanced solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2012-10-12Clinical Trial Update: Multi-center, Open Label, Extension Study of ALN-VSP02 in Cancer Patients Who Have Responded to ALN-VSP02 Treatment [Phase 1]
Phase 1 extension study of ALN-VSP02 in cancer patients who responded to ALN-VSP02 treatment has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-21Clinical Trial Update: A Pharmacokinetic Study to Access How the Body Absorbs and Removes Linifanib in Male Patients With Advanced Solid Tumors. [Phase 1]
Abbott terminated a Phase 1 pharmacokinetic study of Linifanib (ABT-869) in male patients with advanced solid tumors.
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours [Phase 2]
A Phase 2 trial evaluating Cediranib (AZD2171) for advanced solid tumors, also examining hypertension management; the study is completed and…
-
CLINICAL_TRIALS trial_result · 2012-08-28Clinical Trial Update: A Study Evaluating the Bioavailability of Two Formulations of Linifanib and Food Effect on Pharmacokinetics of Linifanib in Subjects With Advanced or Metastatic Solid Tumors [Phase 1]
Update on a Phase 1 pharmacokinetic study evaluating two linifanib formulations and the effect of food on linifanib in patients with solid t…
-
CLINICAL_TRIALS trial_result · 2012-08-13Clinical Trial Update: A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating romidepsin in combination with gemcitabine in pancreatic and other advanced solid tumors has completed with results…
-
CLINICAL_TRIALS trial_result · 2012-08-03Clinical Trial Update: Bortezomib and Temozolomide in Treating Patients With Advanced Refractory Solid Tumors or Melanoma [Phase 1, Phase 2]
A Phase 1/2 study evaluated the combination of bortezomib and temozolomide in adults with advanced refractory solid tumors or melanoma; the …
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: Phase 1/1b Dose Escalation Study Evaluating BSI-201 as a Single Agent and in Combination With Irinotecan in Subjects With Advanced Solid Tumors [Phase 1]
Phase 1/1b dose-escalation study of BSI-201 as a single agent and in combination with Irinotecan in advanced solid tumors; the trial has com…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: RTA 402 in Advanced Solid Tumors or Lymphoid Malignancies [Phase 1]
Phase 1 study of RTA 402 (bardoxolone methyl) in advanced solid tumors and lymphoid malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-27Clinical Trial Update: A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of TH-302 in Patients With Advanced Solid Tumors [Phase 1]
Phase I study evaluating safety, pharmacokinetics, and preliminary anti-tumor activity of evofosfamide (TH-302) in patients with advanced so…
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: A Phase 1 Study of ARQ 197 in Adult Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 study of ARQ 197 in adults with advanced solid tumors provides safety, dose-escalation, and preliminary anti-tumor activity data f…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: An Open-Label, Dose-Escalation Study of AZD2461 [Phase 1]
Open-label, dose-escalation Phase 1 trial of AZD2461 in patients with refractory solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas [Phase 1]
A Phase 1 safety study of SNX-5422 for solid tumor malignancies and lymphoid cancers has been completed.
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: DX-8951f in Treating Children With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 clinical trial update indicates the study evaluating DX-8951f in children with advanced solid tumors or lymphomas has completed. The…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010) [Phase 1]
Phase 1 pediatric trial of Karenitecin in patients with refractory or recurrent solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-23Clinical Trial Update: A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine [Phase 1]
Phase I dose-escalation study of oral SB939 alone or with azacitidine has completed, assessing safety/dosing in solid tumors and hematologic…
-
CLINICAL_TRIALS trial_result · 2012-04-13Clinical Trial Update: QT Interval Prolongation Study of Eribulin Mesylate (E7389) in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating the risk of QT interval prolongation with eribulin mesylate (E7389) in patients with advanced solid tumors; the stu…
-
CLINICAL_TRIALS trial_result · 2012-03-23Clinical Trial Update: To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. [Phase 1]
Phase 1 study comparing the relative bioavailability of two linifanib formulations in patients with solid tumors.